Skip to content
‹ Back to IndustriesHealthcare

Extending Performance Requires A Collaboration Between Different Disciplines

Joel Totoro’s love for professional sports and health has teed him up for a successful career as Director of Sports Science at Thorne. Totoro noticed that the development of a holistic approach has helped extend careers. Teams now include full-time dieticians, psychologists, physical therapists, and the primary care team. “Using health and wellness can be…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Joel Totoro’s love for professional sports and health has teed him up for a successful career as Director of Sports Science at Thorne. Totoro noticed that the development of a holistic approach has helped extend careers. Teams now include full-time dieticians, psychologists, physical therapists, and the primary care team.

“Using health and wellness can be an enhancer in the game,” Totoro recognizes that extended careers are attributed to “the collaboration between different disciplines, nutrition and metabolic, strength coaches, psychologist, taking care of it [wellbeing] from all aspects.” Health is an interconnected system. We’re shifting and becoming more focused on preventative care, and understandably, Totoro says, “is what healthcare should be.”

Thorne is leading the way in quality and effective supplements. Thorne’s supplements are strictly made with rigorous testing and the best ingredients to ensure high quality. Totoro understands that Thorne is in the “service industry, at the end of the day. We want you to be as healthy as you can be for as long as you can be.” If the product isn’t improving the overall quality of life, it’s not doing its job. “[Thorne is] altruistically driven, and that isn’t [a factor] in other supplement companies,” explains Totoro.

In an industry with a bad rap, supplements tend to be a money-driven business. Thorne is setting the bar high in terms of quality control. Many of Thorne’s supplements are backed by NSF Certified for Sport. They provide peace of mind to professional athletes whose livelihood depends on clean testing before a performance. If a supplement had a filler, which may not be dangerous to an individual, but is considered illegal in a sport, the athlete’s career could be on the line. Thorne’s high standards honor that athletes’ careers depend on reliable products.

Thorne offers personalized, scientific testing and solutions so that individuals can create custom supplement regimens. Totoro explains that Thorne empowers its customers with “individual control and understanding.”

While Thorne’s standards are a huge differentiator, Totoro explains, “what’s really exciting is the fact that we have partners in the medical space.” Recently, Thorne developed a supplement for brain health after a concussion with The Mayo Clinic. The supplement gives the brain the nutrients to support cell growth, ultimately benefitting memory and focus.

From professional athletes to laypeople, Thorne provides the tools for individuals to improve and maintain their health. After all, as Totoro says, “you are the CEO of you,” and you have to “do what’s best for you.”

As the CEO of his health, Totoro’s supplement routine is customized. Magnesium is what introduced him to Thorne. And he’s excited about the development of leucine (found in SynaQuell, which supports cognition and focus) and Theanine (helps modify brain waves by increasing alpha-wave production. It also enhances brain neurotransmitters involved in stress management.)

Eric Dickerson Turns His Toughest Career Moments into Lessons for the Next Generation of Players

How College Athletic Departments Should Be Educating Their Athletes on NIL

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

LeanTaaS buys LookDeep Health and brings computer vision into hospital patient rooms

LeanTaaS buys LookDeep Health and brings computer vision into hospital patient rooms

LeanTaaS said on November 3 it acquired LookDeep Health, a computer vision company, and introduced iQueue for Virtual Care, its first product built on what it calls ambient intelligence. Terms were not disclosed. The product bundles Virtual Observation, Virtual Nursing and Virtual Medicine, and LeanTaaS says hospitals can build on compatible cameras and in-room devices already installed or deploy supported hardware. The company cited reported results from LookDeep deployments, including fall-rate reductions of more than 70%, and said LookDeep's technology was evaluated in peer-reviewed research published in Frontiers in Imaging.

  • 01LeanTaaS acquired LookDeep Health and launched iQueue for Virtual Care, combining Virtual Observation, Virtual Nursing and Virtual Medicine; acquisition terms were not disclosed.
  • 02Hospitals can build on compatible cameras and in-room devices already in place or deploy supported hardware, according to LeanTaaS, which did not name camera vendors.
  • 03LeanTaaS reported results from LookDeep deployments including fall-rate reductions of more than 70% and twice as much nursing contact, figures that are the company's own and not tied to named health systems.

Nov 3, 2026

Philips posts 8% order intake growth in Q3 and books a EUR 288 million Respironics provision

Philips posts 8% order intake growth in Q3 and books a EUR 288 million Respironics provision

Royal Philips reported 8% comparable order intake growth for the third quarter of 2026, driven by Diagnosis & Treatment, with comparable sales up 3% to EUR 4.4 billion and an adjusted EBITA margin of 13.0%, up 70 basis points. The company reiterated its 2026 outlook for 3% to 4.5% comparable sales growth. Philips Respironics reached an agreement in principle with the US Department of Justice to resolve previously disclosed investigations related to its recall, and Philips recorded a EUR 288 million provision in the quarter, with payment expected in the first quarter of 2027 subject to final documentation.

  • 01Comparable order intake grew 8%, matching a year earlier, with Diagnosis & Treatment the driver; the equipment order book stands at about 40% of revenue.
  • 02Comparable sales rose 3% to EUR 4.4 billion, adjusted EBITA margin reached 13.0%, and free cash flow was EUR 384 million; the 2026 outlook was reiterated.
  • 03Philips Respironics reached an agreement in principle with the DOJ on previously disclosed recall investigations, and Philips recorded a EUR 288 million provision; the settlement is subject to final documentation.

Nov 3, 2026

Rockwell Medical agrees to buy most of Vantive's hemodialysis business for $125 million

Rockwell Medical agrees to buy most of Vantive's hemodialysis business for $125 million

Rockwell Medical agreed to acquire most of Vantive's hemodialysis business for $125 million in base consideration, plus up to $45 million in contingent payments, with closing expected mid-2027. The deal includes hemodialysis concentrates, machines, water treatment systems, and Vantive's Medolla, Italy manufacturing facility; the combined business could generate $400-450 million annually, depending on various factors.

  • 01Rockwell Medical acquires Vantive's hemodialysis concentrates, AK 98 machines, water treatment systems, and one-million-square-foot Medolla, Italy manufacturing campus for $125 million base price plus up to $45 million contingent on revenue and EBITDA milestones.
  • 02Combined business targeted to generate $400-450 million in annual revenue depending on operating performance, exchange rates, market conditions and integration.
  • 03Vantive's dialyzer portfolio, including Theranova dialyzer for expanded hemodialysis, remains with Vantive; the company will focus on home dialysis and critical care after divestiture.

Nov 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512